AI & Machine Learning

The biological stories told by our internal organs are often more complex than the simple physical blockages visible on a standard medical scan. For years, the gold standard for predicting a heart attack centered on the presence of calcified plaque within the coronary arteries, leaving other

Ivan Kairatov is a distinguished biopharma expert with an extensive background in cardiovascular research and development. With years of experience navigating the intersection of biotechnology and clinical innovation, he has become a leading voice on how emerging technologies reshape heart rhythm

The human gut is no longer viewed as a mere processing plant for nutrients but rather as a sophisticated biochemical engine that dictates the longevity and resilience of the human brain. Recent breakthroughs in medical research have established that the complex communication network between the

The persistent tension between maintaining meticulous medical records and providing high-quality patient care has reached a breaking point within the modern American healthcare infrastructure. While the shift to digital systems was intended to streamline data access and improve safety protocols,

Ivan Kairatov stands at the intersection of biopharmaceutical innovation and clinical technology, bringing years of expertise in research and development to the forefront of oncology care. His work focuses on bridging the gap between raw medical data and actionable clinical insights, particularly

Hypertension remains a primary driver of cardiovascular disease and a persistent public health crisis in the United States, where approximately half of all adults currently live with elevated blood pressure. While clinicians have historically relied on standard dietary advice to manage this